En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este segundo día en el ACC 2026 de Nueva Orleans.

1. Efficacy And Safety Of Sotatercept In Combined Post- And Pre-capillary Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction: Results From The Phase 2 Cadence Trial

2. Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3)

3. A Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina- ORBITA-CTO Trial

4. Mavacamten in Symptomatic Adolescent Patients With Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout-HCM Trial